Kaufman & Broad: Hachemi sells EUR 426,400 while French housing stays under pressure

A builder that still has to sell homes in a hostile rate regime

Kaufman & Broad does not trade like a software name or a bank. It lives and dies with French residential demand, permit flow, mortgage conditions, and the willingness of buyers to sign before the next rate move makes the monthly payment uglier. That is the business. That is also why the stock can look resilient even when the sector is not.

The company’s own H1 2026 numbers help explain why the market has not treated it like a generic housing casualty. Revenue was stable at EUR 500.9 million, operating margin came in at 8%, and orders reached 2,622 units, essentially flat year over year while the broader French new housing market fell 23%.[^1] In a sector where volume is usually the first thing to crack, that kind of relative stability matters more than a tidy narrative about “defensiveness.”

What Hachemi sold, and why the size matters more than the headline

The filing on the AMF database shows Nordine Hachemi, Kaufman & Broad’s chief executive, selling shares on July 27, 2026, with a euro-normalised filing value of about EUR 426,400.[^2][^3] Insiders Trades data marks it as a cluster event, and the role matters here. A chief executive filing carries more weight than a routine director trim because the market knows who has the best line of sight into the order book, the margin bridge, and the next quarter’s tone.

The size is not trivial either. Insiders Trades data pegs the transaction at about 0.08% of the company’s market value, which is large enough to register as a deliberate action rather than a housekeeping sale. The score lands at 5.4, but the number is not the story by itself. The story is that the sale came from the top seat, in a name that has already been trading through a difficult housing cycle, and it arrived alongside other recent declarations in the same window.

The cluster detail deserves a sober read. Insiders Trades data shows six recent declarations, all tied to Hachemi, with both buy and sell entries in the same period. That is messy in the way real filing streams often are. It does not hand you a clean directional thesis. It does tell you the market is seeing repeated activity from the same executive while the company is still trying to defend its relative position in a weak market.

French housing is weak, Kaufman & Broad is weaker only in the aggregate

The macro backdrop is not subtle. The European Central Bank raised its deposit facility rate to 2.25% effective mid-June 2026, while inflation forecasts for 2026 were revised up to 3.0% and euro area growth estimates were trimmed, with some updates putting 2026 GDP around 0.8% or lower.[^4][^5] For housing, that is a rough combination. Higher-for-longer rates keep affordability tight, and the market does not need much imagination to see why transaction volumes stay soft.

Kaufman & Broad has tried to position itself as a relative outperformer inside that mess. In earlier comments cited in recent coverage, Hachemi pointed to market share gains and a focus on permitting processes rather than financing conditions alone.[^1] That is a practical distinction. A builder cannot set the ECB, but it can work the pipeline, the land bank, the permit cadence, and the product mix. In this sector, execution often shows up first in orders, then in revenue, and only later in the stock.

The company’s H1 2026 print suggests that the machine is still turning. Revenue held at EUR 500.9 million, the operating margin stayed at 8%, and orders were flat at 2,622 units even as the broader French new housing market contracted by 23%.[^1] That is not a victory lap. It is a sign that Kaufman & Broad is taking share or at least not losing it as fast as the market around it. For a residential developer, that is the difference between a manageable cycle and a nasty one.

The peer set is not giving you much comfort either

The comparison set reinforces the point. Nexity reported H1 2026 revenue of EUR 1.057 billion, down 18%, and its shares were trading near EUR 6.64 in late July after a sharp post-earnings drop.[^6][^7] That is a different business mix, but the message is familiar. French housing names are still living with the consequences of weak demand and expensive money.

Icade and Bouygues Immobilier have also been moving through the same sector pressure, though the available data gives a less clean week-to-week comparison. The useful point is not that every developer is moving in lockstep. They are not. The useful point is that Kaufman & Broad’s order stability looks better than what the broader market has been delivering, and that relative resilience is part of why the stock can absorb an insider sale without immediately turning into a thesis break.

Fitch affirmed Kaufman & Broad at BBB with a stable outlook on July 13, 2026.[^8] That matters because it tells you the balance sheet and credit profile are not the weak link in the story. In a sector where financing conditions have been the main drag, a stable rating gives the company more room to manage through the cycle than a weaker peer would have. It does not solve demand. It does reduce the chance that the market has to worry about something uglier than a soft order book.

Insiders Trades data puts the filing in a familiar bucket

Insiders Trades data places this in a chief executive bucket at a sweet-spot market cap, specifically chief-executive buys and sells at EUR 300 million to EUR 1 billion names. The historical cohort data for that bucket is not a forecast for this trade, and it should not be treated like one. Over 90 days, the sample of 1,728 names shows a 50.8% win rate and an average return of 5.16%, with a 365 day average return of 41.75%.

That is the right way to use the number. It gives you context for how similar filings have behaved, not a promise that this one will do the same. The sample is large enough to be worth respecting, and the size band is relevant because smaller and mid-cap names have historically been less efficiently priced than the mega-cap end of the market. But the market does not pay you for pretending a historical bucket is a forecast engine.

The strategy headline is available too, but only as a live placeholder token, and only with the caveat that it sits on a restricted EU venue universe and a short, single-regime window. If you want the point-in-time backtest headline, it is 1.17, 12.5% (STOXX Europe 600 on the same dates: 9.3%), and (figure withdrawn, see audit 231). That is a framework read, not an alpha claim. The point here is narrower: the filing fits a pattern our scoring has historically paid attention to, and the pattern is more interesting when the company is already operating in a stressed sector.

Why the business model matters more than the filing mechanics

Kaufman & Broad makes money by turning land, permits, and execution into delivered homes and related development revenue. That sounds plain because it is plain. The hard part is not the accounting. It is the timing. A builder can look fine on paper while permits lag, buyers hesitate, or financing conditions shift under the customer base. The stock usually reacts to that timing before it reacts to the annual report.

That is why the H1 2026 figures matter more than the sale in isolation. Stable revenue and an 8% operating margin tell you the company has not yet been forced into the kind of discounting that destroys a cycle. Orders at 2,622 units, flat against a market down 23%, tell you management has not lost the commercial battle outright.[^1] If you are looking for the real tension in the name, it is there. The company is doing better than the market, but the market is still bad.

The insider sale sits on top of that. A chief executive selling EUR 426,400 of stock while the company is defending share and margin is not the same thing as a boardroom panic signal. It is also not the kind of purchase that screams obvious upside. It is a data point. In a sector where the operating backdrop is still fragile, a sale from the top seat asks you to stay alert to whether the relative resilience in H1 can persist into the second half.

What would change the read from here

The next useful markers are operational, not theatrical. You want to see whether order intake keeps holding up against the broader French housing market, whether the 8% operating margin survives if pricing pressure returns, and whether management keeps talking about permit flow and market share in a way that matches the numbers rather than the slide deck.[^1] If those pieces stay intact, the July sale will look more like portfolio management than a warning flare.

You also want to watch the sector backdrop. The ECB’s higher-for-longer stance is not a one-day event, and housing affordability does not reset because one builder had a decent half. If rates stay restrictive and inflation stays sticky, the market will keep testing whether Kaufman & Broad’s relative strength is real or just a better patch in a weak tape. The company’s BBB stable rating gives it room, but not immunity.[^8]

For now, the filing adds caution, not drama. The business still has the better numbers than many domestic peers, the sector still has the worse macro, and the chief executive just sold EUR 426,400 worth of stock through the AMF. That is enough to keep on the screen, especially with the next trading update and order commentary still ahead.

[^1]: Recent company results and commentary as reported by Investing.com, including H1 2026 revenue of EUR 500.9 million, 8% operating margin, 2,622 units ordered, and a 23% decline in the broader French new housing market. [^2]: InsiderScreener company page for Kaufman & Broad SA. [^3]: AMF filing, declaration ID 2026DD1129215. [^4]: European Central Bank press release on the June 2026 deposit facility rate decision. [^5]: Degroof Petercam July 2026 macro house view. [^6]: Nexity H1 2026 results coverage. [^7]: StockAnalysis and related market data for Nexity SA. [^8]: Fitch Ratings affirmation of Kaufman & Broad at BBB with stable outlook.

Dig deeper: Kaufman & Broad SA's full insider filing history.

This is not investment advice.